期刊
DIABETES CARE
卷 37, 期 9, 页码 2466-2474出版社
AMER DIABETES ASSOC
DOI: 10.2337/dc13-2536
关键词
-
资金
- Novo Nordisk
- Novo Nordisk A/S
- Eli Lilly
- Sanofi
- Merck Serono
- Novartis
- Bristol-Myers Squibb
- Janssen
- Abbott
- LifeScan
- Roche Diagnostics
- Bayer Diagnostics
- Dexcom
- AbbVie
- Pfizer
- BD
- Merck
- Bayer
- Bristol-Myers Squibb-Amylin
- Roche-Genentech
- Tethys
OBJECTIVE To identify the psychosocial experiences of diabetes, including negative accounts of diabetes and adaptive ways of coping from the perspective of the person with diabetes. RESEARCH DESIGN AND METHODS Participants were 8,596 adults (1,368 with type 1 diabetes and 7,228 with type 2 diabetes) in the second Diabetes Attitudes, Wishes and Needs (DAWN2) study. Qualitative data were responses to open-ended survey questions about successes, challenges, and wishes for improvement in living with diabetes and about impactful experiences. Emergent coding developed with multinational collaborators identified thematic content about psychosocial aspects. The kappa measure of interrater reliability was 0.72. RESULTS Analysis identified two negative psychosocial themes: 1) anxiety/fear, worry about hypoglycemia and complications of diabetes, depression, and negative moods/hopelessness and 2) discrimination at work and public misunderstanding about diabetes. Two psychosocial themes demonstrated adaptive ways of coping with diabetes: 1) having a positive outlook and sense of resilience in the midst of having diabetes and 2) receiving psychosocial support through caring and compassionate family, friends, health care professionals, and other people with diabetes. CONCLUSIONS The personal accounts give insight into the psychosocial experiences and coping strategies of people with diabetes and can inform efforts to meet those needs and capitalize on strengths.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据